Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study
Crossref DOI link: https://doi.org/10.1007/s00280-017-3268-y
Published Online: 2017-03-13
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tandia, Mahamadou
Mhiri, Asma
Paule, Bernard
Saffroy, Raphaël
Cailliez, Valérie
Noé, Gaëlle
Farinotti, Robert
Bonhomme-Faivre, Laurence
License valid from 2017-03-13